White label ELPA - ClinicalTrials.eu

Evaluation of fenofibrate treatment on beta cell function in children and adolescents newly diagnosed with type 1 diabetes

Not recruiting

2 1 1
Investigated Drugs:
- Fenofibrate Micronised
Study on the Safety and Effectiveness of Brexucabtagene Autoleucel for Children and Teens with Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

Not recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Brexucabtagene Autoleucel
Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Not recruiting

3 1 1
Investigated Drugs:
- Efgartigimod Alfa
+4
Study on Coagulation Differences Using Fresh Frozen Plasma and Solvent-Detergent Plasma in Children Undergoing Congenital Heart Surgery

Not recruiting

3 1 1 1
Investigated Diseases:
- Coagulopathy
Investigated Drugs:
- Human Plasma Protein
- Plasma
Study on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Metastatic renal cell carcinoma
Investigated Drugs:
- Pembrolizumab
Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Not recruiting

3 1
Investigated Drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
+4
Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Not recruiting

3 1
Investigated Drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
+4
Study on Belantamab Mafodotin with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Not recruiting

1 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
Study of sulthiame combined with oral appliance therapy for patients with obstructive sleep apnea who have incomplete response to oral appliance treatment alone

Not recruiting

2 1 1
Investigated Diseases:
- Obstructive sleep apnoea syndrome
Investigated Drugs:
- Sultiame
Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

Not recruiting

1 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
- Non-small cell lung cancer recurrent
Investigated Drugs:
- Cln-081

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies